PPCB Stock Analysis: Buy, Sell, or Hold?
PPCB - Propanc Biopharma, Inc. Common Stock
$1.77
0.33 (22.92%)
▲
5d:
+17.22%
30d:
+0.0%
90d:
+1484.6%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When PPCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PPCB shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: PPCB shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PPCB is currently trading at $1.77, which is considered fair relative to its 30-day fair value range of $1.40 to $1.93.
Technical Outlook: Technically, PPCB is in a uptrend. Immediate support is located at $1.31, while resistance sits at $1.98. The stock is showing strong short-term momentum, up 22.9% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.52. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PPCB is in a uptrend. Immediate support is located at $1.31, while resistance sits at $1.98. The stock is showing strong short-term momentum, up 22.9% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.52. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.40 -
$1.93
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Strong upward momentum (+22.9%)
- BEARISH: Trading 14.1% above Wall St target ($1.52)
Trading Range Analysis
30-Day Trading Range
$1.40 -
$1.93
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.31
Resistance Level
$1.98
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$1.52
(-14.1%)
Share & Embed Analysis
Last updated: July 03, 2026 3:46 PM ET
Data refreshes hourly during market hours. Next update: 4:46 PM
Data refreshes hourly during market hours. Next update: 4:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PPCB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 57 HOLD |